The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


Time/Date Code Headline Source Impact
16:31 08-Nov-2017 SNG Holding(s) in Company RNS -2.95% Down
07:00 27-Sep-2017 SNG Interim results for six months ended 30 June 2017 RNS +6.28% Up
07:00 27-Sep-2017 SNG Data update and clinical plan for COPD RNS +6.28% Up
12:44 13-Sep-2017 SNG Holding(s) in Company RNS +6.70% Up
07:00 06-Sep-2017 SNG LOXL2 Inhibitor Update. RNS +47.70% Up
12:41 28-Jun-2017 SNG Result of AGM RNS +1.16% Up
07:00 05-Jun-2017 SNG Posting of Annual Report and Notice of AGM RNS -0.24% Down
07:00 17-May-2017 SNG Preliminary Results RNS -4.44% Down
07:00 27-Apr-2017 SNG AZD9412 Update RNS -52.52% Down
07:00 27-Mar-2017 SNG Holding(s) in Company RNS -2.64% Down
15:10 13-Mar-2017 SNG Holding(s) in Company RNS +9.94% Up
08:34 10-Mar-2017 SNG Additional Positive Data in Lung Fibrosis RNS +11.18% Up
14:46 17-Jan-2017 SNG Holding(s) in Company RNS +20.03% Up

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.


Company Information
Updated Monthly
Company address Mailpoint 810, Level F, South Block, Southampton General Hospital, Southampton, SO16 6YD, United Kingdom
Company website
Market cap(in millions)* £ 10.51
Listing/Admission to trading 26 Oct 2004
Trading service SEAQ
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment AIMI
MiFID Status MTF
Exchange market size 10,000
ISIN number GB00B0381Z20

SYNAIRGEN share news analysis (SNG)